Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AnaptysBio, Inc. - Common Stock (NQ:ANAB)

49.03 +4.36 (+9.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	673,053
Open	44.54
Bid (Size)	43.00 (100)
Ask (Size)	50.50 (100)
Prev. Close	44.67
Today's Range	44.45 - 50.00
52wk Range	12.21 - 52.47
Shares Outstanding	27,433,359
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally ↗

January 11, 2026

This biotech innovator in antibody therapies just reported a significant insider sale amid a period of strong share price gains.

Via The Motley Fool

What Investors Should Know About a $163K AnaptysBio Insider Sale ↗

January 11, 2026

This clinical-stage biotech specializing in antibody therapeutics reported a notable insider sale amid ongoing development and partnerships.

Via The Motley Fool

Performance

YTD	+9.1%	+9.1%
1 Month	+7.6%	+7.6%
3 Month	+51.0%	+51.0%
6 Month	+81.9%	+81.9%
1 Year	+235.4%	+235.4%

More News

Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

January 08, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

ANAB Stock Falls After It Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal ↗

November 21, 2025

Via Stocktwits

AnaptysBio Stock Gets A Price Target Hike After Announcing Plan To Separate Royalty, Biopharma Businesses – Check Out The New Level ↗

September 30, 2025

Via Stocktwits

Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 06, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio Inc (NASDAQ:ANAB) Meets Minervini Trend Template with High-Growth Momentum ↗

December 20, 2025

Via Chartmill

Anaptys Announces Participation in December Investor Conferences

November 25, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio Inc (NASDAQ:ANAB) Screens as a High-Growth Momentum Leader ↗

November 22, 2025

Via Chartmill

Anaptys Announces $100 Million Stock Repurchase Plan

November 21, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary

November 21, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

ANAPTYSBIO INC (NASDAQ:ANAB) Shows High-Growth Momentum and Positive Technical Setup ↗

November 13, 2025

Via Chartmill

AnaptysBio To Save $10 Million After Discontinuing Ulcerative Colitis Study ↗

November 10, 2025

Via Benzinga

Why AnaptysBio Stock Plummeted, Reversing A 70% Monthlong Run ↗

November 10, 2025

Via Investor's Business Daily

Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis

November 10, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Announces Participation in November Investor Conferences

November 04, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update

November 04, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation

October 29, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025

October 13, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

Wall Street Climbs Despite Shutdown Risk — Pfizer and CoreWeave Shine Bright ↗

October 01, 2025

Via Chartmill

Here are the top movers in Tuesday's session. ↗

September 30, 2025

Via Chartmill

AnaptysBio Charts Path To Split Into Two Public Companies By 2026 ↗

September 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 30, 2025

Via Benzinga

United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday ↗

September 30, 2025

Via Benzinga

Tuesday's session: gap up and gap down stocks ↗

September 30, 2025

Via Chartmill

Frequently Asked Questions

Is AnaptysBio, Inc. - Common Stock publicly traded?

Yes, AnaptysBio, Inc. - Common Stock is publicly traded.

What exchange does AnaptysBio, Inc. - Common Stock trade on?

AnaptysBio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for AnaptysBio, Inc. - Common Stock?

The ticker symbol for AnaptysBio, Inc. - Common Stock is ANAB on the Nasdaq Stock Market

What is the current price of AnaptysBio, Inc. - Common Stock?

The current price of AnaptysBio, Inc. - Common Stock is 49.03

When was AnaptysBio, Inc. - Common Stock last traded?

The last trade of AnaptysBio, Inc. - Common Stock was at 01/12/26 04:00 PM ET

What is the market capitalization of AnaptysBio, Inc. - Common Stock?

The market capitalization of AnaptysBio, Inc. - Common Stock is 1.35B

How many shares of AnaptysBio, Inc. - Common Stock are outstanding?

AnaptysBio, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.